Investigating the comparative effect of high-dose intravenous sulbactam ampicillin with and without amikacin nebulizer in the treatment of patients with ventilator-associated pneumonia caused by resistant Acinetobacter bacteria.
Phase 3
- Conditions
- Ventilator-dependent pneumonia due to resistant Acinetobacter.
- Registration Number
- IRCT20240529061949N1
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 72
Inclusion Criteria
All patients over 18 years old with ventilator-dependent pneumonia due to resistant Acinetobacter
Exclusion Criteria
Immunocompromised patients and extubated patients
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method